Table 1. Clinicopathological characteristics of the ICI (n=1,661) and non-ICI (n=3,840) groups.

Characteristic	ICI group No. (%)	Non-ICI group No. (%)
Age median (range)	63 (15–90)	NA
Sex
Male	1,034 (62.3)	1,582 (41.2)
Female	627 (37.7)	2,258 (58.8)
Cancer type
Bladder	215 (12.9)	190 (4.9)
Breast	44 (2.6)	926 (24.1)
Colorectal	110 (6.6)	637 (16.5)
Esophagogastric	126 (7.6)	218 (5.6)
Glioma	117 (7.0)	343 (8.9)
Head and neck	139 (8.4)	84 (2.1)
Melanoma	321 (19.3)	123 (3.2)
Non-small cell lung	350 (21.1)	1,293 (33.6)
Renal cell carcinoma	151 (9.1)	149 (3.6)
Unknown primary	88 (5.3)	139 (3.6)
Drug type
PD-1/PD-L1	1,307 (78.7)	NA
CTLA-4	99 (6.0)	NA
Combo	255 (15.3)	NA
Gene panel
IMPACT341	230 (13.8)	933
IMPACT410	1,001 (60.3)	2,907
IMPACT468	430 (25.9)	0
Status
Living	829 (49.9)	2,734 (71.9)
Decreased	832 (50.1)	1,106 (28.1)